Search results
Stock market update: Nifty Pharma index advances 1.39%
The Economic Times· 5 days agoThe Nifty Pharma index closed 1.39 per cent up at 20192.6.
Here's why CA Rudramurthy BV is bullish on IRCTC
The Economic Times· 5 days ago"In fact, today dip whatever you got in market early morning because of HDFC Bank business update and because of which markets fell, that was again an...
Budget Wish List: Pharma Industry Seeks Tax Benefits, Effective Intellectual Property Rights Regime
Latest India News· 3 days agoGiven the high risk, lengthy development periods, and low success rates in research, continuous...
Budget wish list: Pharma industry seeks tax benefits, effective intellectual property rights regime
CNBC Awaaz· 3 days agoOutlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical...
Short Call: Mutual fund investors chase momentum; capex cycle, Lupin, ITC, Persistent, Inox Wind in...
CNBC Awaaz· 5 days ago“Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble.” Warren...
Budget wish list: Pharma industry seeks tax benefits, effective intellectual property rights regime...
CNBC TV18· 3 days agoBusiness News: Get the latest Business News, Live Share & Stock Market Updates, Top News from India...
Bajaj Auto, Hero, TVS, Eicher Motors, others: Steady 7-9% FY25 volume growth expectations for...
Livemint· 1 day agoStock Market today: Bajaj Auto, Hero MotoCorp , Eicher Motors, TVS Motor Company share prices have...
Nifty, Sensex shed all gains, end flat amid volatility; IT, healthcare shine
CNBC Awaaz· 5 days agoBenchmark indices Nifty and Sensex shed almost all gains to end the day marginally higher on July 4...
India set to witness obesity pill revolution? As patents near expiry, pharma giants gear up for...
Financial Express· 2 days agoBlockbuster obesity drugs like Ozempic and Wegovy have become a global sensation. Now the Indian...
Should investors bet on large-cap pharma stocks? Alok Agarwal answers
The Economic Times· 2 days agoAlok Agarwal: We have been seeing a K-shaped recovery all through, especially after COVID, and that...